Results 41 to 50 of about 2,227,737 (406)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejection
Marat Fudim   +14 more
doaj   +1 more source

Improvement of a Prediction Model for Heart Failure Survival through Explainable Artificial Intelligence [PDF]

open access: yes, 2021
Cardiovascular diseases and their associated disorder of heart failure are one of the major death causes globally, being a priority for doctors to detect and predict its onset and medical consequences. Artificial Intelligence (AI) allows doctors to discover clinical indicators and enhance their diagnosis and treatments.
arxiv   +1 more source

Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Adoption of guideline-directed medical therapy for patients with heart failure is variable. Interventions to improve guideline-directed medical therapy have failed to consistently achieve target metrics, and limited data exist to inform ...
A. DeVore   +20 more
semanticscholar   +1 more source

The diagnostic value of peroxisome proliferator-activated receptor-γ coactivator-1α in identifying different chronic heart failure phenotypes

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundDespite advances in diagnosing and treating chronic heart failure (HF), the underlying mechanisms in different HF phenotypes remain unclear. Mitochondrial energy metabolism is crucial in HF etiology.
Shiwen Zhang   +6 more
doaj   +1 more source

The Treatment of Heart Failure with Reduced Ejection Fraction

open access: yesDeutsches Ärzteblatt international, 2020
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.This review is based on articles retrieved by a selective search in PubMed, as well as on relevant guidelines.Evidence-based treatment options are available only for ...
Johann Bauersachs   +2 more
openaire   +3 more sources

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.

open access: yesJAMA cardiology, 2021
Importance It is unclear how New York Heart Association (NYHA) functional class compares with patient-reported outcomes among patients with heart failure (HF) in contemporary US clinical practice.
S. Greene   +12 more
semanticscholar   +1 more source

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction

open access: yesESC Heart Failure, 2022
Aims Evidence on the association between ambient temperature and the onset of acute heart failure (AHF) is scarce and mixed. We sought to investigate the incidence of AHF admissions based on ambient temperature change, with particular interest in ...
Takahiro Jimba   +19 more
doaj   +1 more source

Insulin Resistance Is Associated With Heart Failure With Recovered Ejection Fraction in Patients Without Diabetes

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Because of advances in medical treatments, a substantial proportion of patients with heart failure (HF) have experienced recovery of ejection fraction (EF), termed HF with recovered EF (HFrecEF).
Chen Die Yang   +11 more
doaj   +1 more source

The role of interleukins in heart failure with reduced ejection fraction [PDF]

open access: yesThe Anatolian Journal of Cardiology, 2019
Heart failure (HF) is the leading cause of morbidity and mortality in developed countries, and it is the primary cause of mortality in the elderly worldwide. The processes of inflammatory response activation, production and release of pro-inflammatory cytokines, activation of the complement system, synthesis of autoantibodies, and overexpression of ...
Ewa Nowalany-Kozielska   +4 more
openaire   +4 more sources

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less.
S. Solomon   +41 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy